Announced Fri, 19 Jun · 16:58 IST
Albert David appoints Amit Mahla as Additional Director and Whole-time Director & CEO for 5 years
ALBERTDAVD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.5%1-day move
₹710.50
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+0.5+0.2-0.7-0.4-1.8+0.9-2.2-3.3——
Up moveDown movePending
AI summary
Albert David's Board has appointed Mr. Amit Mahla as Additional Director and Whole-time Director and CEO for 5 years (June 19, 2026 to June 18, 2031). He was already serving as CEO since May 12, 2026. Remuneration is fixed till March 31, 2027. Both appointments need shareholder approval at the 87th AGM. Mr. Mahla, 52, has 28 plus years in pharma with companies like Cipla, Glenmark, Sun Pharma, and JB Pharma.
Likely market impact
Formalizes leadership for 5 years with experienced pharma hand from JB Pharma. Brings continuity but pending shareholder nod at the 87th AGM.